Percutaneous sclerotherapy of lymphatic malformations with doxycycline

Lymphatic Research and Biology

Volumn 6, Issue 3-4, 2008, Pages 209-216

  Burrows, Patricia E ^a,b   Mitri, Ragheed K ^a   Alomari, Ahmad ^a   Padua, Horacio M ^a   Lord, David J ^a   Sylvia, Mary Beth ^a   Fishman, Steven J ^a   Mulliken, John B ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CYSTIC LYMPHANGIOMA; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FEMALE; HUMAN; INFANT; INJECTION SITE SWELLING; MALE; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCLEROTHERAPY; TREATMENT RESPONSE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DOXYCYCLINE; FEMALE; HUMANS; INFANT; LYMPHATIC ABNORMALITIES; LYMPHATIC SYSTEM; MALE; RETROSPECTIVE STUDIES; SCLEROSING SOLUTIONS; SCLEROTHERAPY; TREATMENT OUTCOME;

EID: 58149085433     PISSN: 15396851     EISSN: None     Source Type: Journal    
DOI: 10.1089/lrb.2008.1004     Document Type: Article

References (53)

1. Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg 2000;37:517-584.
2. Smith RJ, Burke DK, Sato Y, Poust RI, Kimura K, Bauman NM. OK-432 therapy for lymphangiomas. Arch Otolaryngol-Head Neck Surg 1996;122:1195-1199.
3. Laranne J, Keski-Nisula L, Rautio R, Rautiainen M, Airaksinen M. OK-432 (Picibanil) therapy for lymphangiomas in children. Eur Arch Oto-Rhino-Laryngol 2002;259:274-278.
4. Tovi M, Herbreteau D, Enjolras O, Merland JJ. [52 patients with cystic lymphatic vascular malformations. Percutaneous sclerotherapy - simple, fast and repeatable]. Lakartidningen 1998;95:643-647.
5. Sanlialp I, Karnak I, Tanyel FC, Senocak ME, Buyukpamukcu N. Sclerotherapy for lymphangioma in children. Int J Pediatr Otorhinolaryngol 2003;67:795-800.
6. Alomari AI, Karian VE, Lord DJ, Padua HM, Burrows PE. Percutaneous sclerotherapy for lymphatic malformations: A retrospective analysis of patient-evaluated improvement. J Vasc Interv Radiol 2006;17:1639-1648.
7. Lee BB. New approaches to the treatment of congenital vascular malformations (CVMs) - a single centre experience. Eur J Vasc Endovasc Surg 2005;30:184-197.
8. Puig S, Aref H, Brunelle F. Double-needle sclerotherapy of lymphangiomas and venous angiomas in children: A simple technique to prevent complications. AJR Am J Roentgenol 2003;180:1399-1401.
9. Sung MW, Chang SO, Choi JH, Kim JY. Bleomycin sclerotherapy in patients with congenital lymphatic malformation in the head and neck. Am J Otolaryngol 1995;16:236-241.
10. Sung MW, Lee DW, Kim DY, Lee SY, Hwang CH, Park SW, Kim KH. Sclerotherapy with picibanil (OK-432) for congenital lymphatic malformation in the head and neck. Laryngoscope 2001;111:1430-1433.
11. Giguere CM, Bauman NM, Sato Y, Burke DK, Greinwald JH, Pransky S, Kelley P, Georgeson K, Smith RJ. Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: a prospective multi-institutional trial. Arch Otolaryngol - Head Neck Surg 2002;128:1137-1144.
12. Luzzatto C, Midrio P, Tchaprassian Z, Guglielmi M. Sclerosing treatment of lymphangiomas with OK-432. Arch Dis Child 2000;82:316-318.
13. Won JH, Kim BM, Kim CH, Park SW, Kim MD. Percutaneous sclerotherapy of lymphangiomas with acetic acid. J Vasc Interv Radiol 2004;15:595-600.
14. Rautio R, Keski-Nisula L, Laranne J, Laasonen E. Treatment of lymphangiomas with OK-432 (Picibanil). Cardiovasc Intervent Radiol 2003;26:31-36.
15. Emran MA, Dubois J, Laberge L, Al-Jazaeri A, Butter A, and Yazbeck S. Alcoholic solution of zein (Ethibloc) sclerotherapy for treatment of lymphangiomas in children. J Pediatr Surg 2006;41:975-979.
16. Molitch HI, Unger EC, Witte CL, vanSonnenberg E. Percutaneous sclerotherapy of lymphangiomas. Radiology 1995;194:343-347.
17. Cordes BM, Seidel FG, Sulek M, Giannoni CM, Friedman EM. Doxycycline sclerotherapy as the primary treatment for head and neck lymphatic malformations. Otolaryngol Head Neck Surg 2007;137:962-964.
18. Nehra D, Jacobson L, Barnes P, Mallory B, Albanese CT, Sylvester KG. Doxycycline sclerotherapy as primary treatment of head and neck lymphatic malformations in children. J Pediatr Surg 2008;43:451-460.
19. Bloom DC, Perkins JA, Manning SC. Management of lymphatic malformations. Curr Opin Otolaryngol Head Neck Surg 2004;12:500-504.
20. Burrows PE, Laor T, Paltiel H, Robertson RL. Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin 1998;16:455-488.
21. Hancock BJ, St-Vil D, Luks FI, Di Lorenzo M, Blanchard H. Complications of lymphangiomas in children. J Pediatr Surg 1992;27:220-224; discussion 224-226.
22. Laurian C. [Vascular malformations of the limbs. Role of vascular and reconstructive surgery]. J Mal Vasc 1992;17:57-60.
23. Gao Q, Wang C, Wen Y. [A study of effects of pingyangmycin injection on treatment of lymphangiomas in oral, maxillofacial and cervical regions]. Hua Xi Kou Qiang Yi Xue Za Zhi 2002;20:184-186.
24. Zulfiqar MA, Zaleha AM, Zakaria Z, Amin T. The treatment of neck lymphangioma with intralesional injection of bleomycin. Med J Malaysia 1999;54:478-481.
25. Orford J, Barker A, Thonell S, King P, Murphy J. Bleomycin therapy for cystic hygroma. J Pediatr Surg 1995;30:1282-1287.
26. Muir T, Kirsten M, Fourie P, Dippenaar N, Ionescu GO. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations. Pediatr Surg Int 2004;19:766-773.
27. Baskin D, Tander B, Bankaoglu M. Local bleomycin injection in the treatment of lymphangioma. Eur J Pediatr Surg 2005;15:383-386.
28. Mathur NN, Rana I, Bothra R, Dhawan R, Kathuria G, Pradhan T. Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck. Int J Pediatr Otorhinolaryngol, 2005;69:75-80.
29. Al-Salem AH.. Lymphangiomas in infancy and childhood. Saudi Med J 2004;25:466-469.
30. Zhong PQ, Zhi FX, LicR, Xue JL, Shu GY. Long-term results of intratumorous bleomycin-A5 injection for head and neck lymphangioma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1998;86:139-144.
31. Gericke KR. Doxycycline as a sclerosing agent. Ann Pharmacother 1992;26:648-649.
32. Mikhail M, Kennedy R, Cramer B, Smith T. Sclerosing of recurrent lymphangioma using OK-432. J Pediatr Surg 1995;30:1159-11160.
33. Greinwald JH, Jr, Burke DK, Sato Y, Poust RI, Kimura K, Bauman NM, Smith RJ. Treatment of lymphangiomas in children: An update of Picibanil (OK-432) sclerotherapy. Otolaryngol Head Neck Surg 1999;121:381-387.
34. Samuel M, McCarthy L, Boddy SA. Efficacy and safety of OK-432 sclerotherapy for giant cystic hygroma in a newborn. Fetal Diagn Ther 2000;15:93-96.
35. Kuwabara Y, Sawa R, Otsubo Y, Yoneyama Y, Asakura H, Araki T, Takeshita T. Intrauterine therapy for the acutely enlarging fetal cystic hygroma. Fetal Diagn Ther 2004;19:191-194.
36. Hurewitz AN, Wu CL, Mancuso P, Zucker S. Tetracycline and doxycycline inhibit pleural fluid metalloproteinases. A possible mechanism for chemical pleurodesis. Chest 1993;103:1113-1117.
37. Lohela P. Ultrasound-guided drainages and sclerotherapy. Eur Radiol 2002;12:288-295.
38. Caliendo MV, Lee DR, Queiroz R, Waldman DL, Sclerotherapy with use of doxycycline after percutaneous drainage of postoperative lymphoceles. J Vasc Interv Radiol 2001;12:73-77.
39. Mansson T. Treatment of malignant pleural effusion with doxycycline. Scand J Infect Dis Suppl 1988;53:29-34.
40. Herrington JD, Gora-Harper ML, Salley RK. Chemical pleurodesis with doxycycline 1 g. Pharmacotherapy 1996;16:280-285.
41. Hoffer FA, Hancock ML, Hinds PS, Oigbokie N, Rai SN, Rao B. Pleurodesis for effusions in pediatric oncology patients at end of life. Pediatr Radiol 2007;37:269-273.
42. Hoff DS, Gremmels DB, Hall KM, Overman DM, Moga FX. Dosage and effectiveness of intrapleural doxycycline for pediatric postcardiotomy pleural effusions. Pharmacotherapy 2007;27:995-1000.
43. Hurewitz AN, Lidonicci K, Wu CL, Reim D, Zucker S. Histologic changes of doxycycline pleurodesis in rabbits. Effect of concentration and pH. Chest 1994;106:1241-1245.
44. Mitchem RE, Herndon BL, Fiorella RM, Molteni A, Battie CN, Reisz GR. Pleurodesis by autologous blood, doxycycline, and talc in a rabbit model. Ann Thorac Surg 1999;67:917-921.
45. Teixeira LR, Wu W, Chang DS, Light RW. The effect of corticosteroids on pleurodesis induced by doxycycline in rabbits. Chest 2002;121:216-219.
46. Kirse DJ, Suen JY, Stern SJ, Schaefer RF, Roberson PK. Histologic effect of doxycycline sclerotherapy on rat femoral nerve. Head Neck 1996;18:506-511.
47. Kirse DJ, Stern SJ, Suen JY, Rudnicki S, Roberson PK, Schaefer RF. Neurotic effects of doxycycline sclerotherapy. Otolaryngol Head Neck Surg 1998;118:356-362.
48. Liao H, Guo Y, Jun Na M, Lane KB, Light RW. The shortterm administration of ketoprofen does not decrease the effect of pleurodesis induced by talc or doxycycline in rabbits. Respir Med 2007;101:963-968.
49. Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol 2004;15:431-445.
50. Maeda Y, Arima K, Matsuura H, Hayashi N, Yanagawa M, Kawamura J. Percutaneous sclerotherapy for chyluria with leg edema: a case report. Hinyokika Kiyo-Acta Urologica Japonica 1998;44:25-27.
51. Shiels WE, 2nd, Kenney BD, Caniano DA, Besner GE. Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities. J Pediatr Surg 2008;43:136-139; discussion 140.
52. Tang SJ, Sreenarasimhaiah J, Tang L, Rollins N, Purdy PD. Endoscopic injection sclerotherapy with doxycycline for mediastinal and esophageal lymphangiohemangioma. Gastrointest Endosc 2007;66:1196-1200.
53. Wimmershoff MB, Schreyer AG, Glaessl A, Geissler A, Hohenleutner U, Feuerbach SS, Landthaler M. Mixed capillary/lymphatic malformation with coexisting port-wine stain: treatment utilizing 3D MRI and CT-guided sclerotherapy. Dermatol Surg 2000;26:584-587.